A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
ModernaTX, Inc.
ModernaTX, Inc.
Regeneron Pharmaceuticals
GlaxoSmithKline
Karyopharm Therapeutics Inc
Genmab
Dana-Farber Cancer Institute
Incyte Corporation
Regeneron Pharmaceuticals
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Zhejiang ACEA Pharmaceutical Co. Ltd.
Hoffmann-La Roche
Chengdu Zenitar Biomedical Technology Co., Ltd
Multiple Myeloma Research Consortium
Celgene
Celgene
Altor BioScience
Stemline Therapeutics, Inc.
Beijing Mabworks Biotech Co., Ltd.
LaNova Medicines Limited
Oncotherapeutics
Takeda
Karyopharm Therapeutics Inc
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
Gilead Sciences
University of Athens
Sun Yat-sen University
Novartis
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
NYU Langone Health
University Health Network, Toronto
Oncotherapeutics
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Ottawa Hospital Research Institute
Biogen
SCRI Development Innovations, LLC
University of Regensburg
Fred Hutchinson Cancer Center
Janssen Pharmaceutical K.K.
Fred Hutchinson Cancer Center
University of Wuerzburg
Attenuon